| Identification | Back Directory | [Name]
2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one | [CAS]
1253731-24-6 | [Synonyms]
3R)-Voruciclib
(2S,3R)-Voruciclib
(2S,3R)Voruciclib,(2S,3R) Voruciclib
2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one | [Molecular Formula]
C22H19ClF3NO5 | [MDL Number]
MFCD32664442 | [MOL File]
1253731-24-6.mol | [Molecular Weight]
469.838 |
| Hazard Information | Back Directory | [Uses]
rel-(2S,3R)-Voruciclib is the (2S,3R)-enantiomer of Voruciclib. (2S,3R)-Voruciclib is an orally active CDK inhibitor[1]. | [References]
[1] Veena Agarwal, et al. A synergistic pharmaceutical combination for the treatment of pancreatic cancer. WO2012123889A1. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|